Mphasis Approves Employee Stock Benefits: 25,000 Options and 7,500 RSUs Granted

2 min read     Updated on 06 Nov 2025, 11:55 PM
scanx
Reviewed by
Shriram ShekharScanX News Team
Overview

Mphasis Limited has approved employee stock benefits, granting 25,000 stock options under ESOP 2016 and 7,500 Restricted Stock Units (RSUs) under RSU Plan 2021. The stock options have an exercise price of ₹2,700 per option, while RSUs are priced at ₹10 per unit. Both have a 5-year vesting period with varying vesting ratios. The benefits will be administered through employee trusts and are subject to SEBI regulations.

23999162

*this image is generated using AI for illustrative purposes only.

Mphasis Limited, a leading IT services and solutions provider, has announced the approval of employee stock benefits through its ESOP Compensation Committee. The company has granted a total of 25,000 stock options and 7,500 Restricted Stock Units (RSUs) to identified employees of the company and its subsidiaries.

Stock Options Grant Details

The company has granted 25,000 stock options under the Employee Stock Option Plan 2016 (ESOP 2016) with the following terms:

Particular Detail
Exercise Price ₹2,700.00 per option
Vesting Period 5 years in equal proportions
Exercise Period 60 months from the respective date of vesting
Administration Through Mphasis Employees Equity Reward Trust

Each option entitles the holder to apply for one equity share of the company with a face value of ₹10.00.

Restricted Stock Units (RSUs) Grant Details

Additionally, 7,500 RSUs have been granted under the Restricted Stock Units Plan 2021 (RSU Plan 2021) with the following terms:

Particular Detail
Exercise Price ₹10.00 per RSU
Vesting Period 5 years in the ratio of 10:10:20:30:30
Exercise Period Automatic exercise for US employees; 60 months from vesting date for others
Administration Through Mphasis Employees Benefit Trust

The RSU plan includes automatic exercise provisions, particularly for US employees subject to Internal Revenue Code requirements. Non-US employees have the option to elect either automatic exercise or exercise by notice.

Implementation and Governance

Both the stock options and RSUs will be administered through employee trusts - the Mphasis Employees Equity Reward Trust for stock options and the Mphasis Employees Benefit Trust for RSUs. The shares arising from the exercise of these stock benefits are proposed to be allotted through these trusts.

The grants are subject to the provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and are governed by their respective plans, which were submitted to the stock exchanges at the time of obtaining in-principle approval.

This move by Mphasis aligns with industry practices of offering equity-based compensation to attract and retain talent, potentially fostering a sense of ownership among employees and aligning their interests with those of the company's shareholders.

Investors and stakeholders may view this development as a positive step towards employee retention and motivation, which could contribute to the company's long-term growth and performance in the competitive IT services sector.

Historical Stock Returns for Mphasis

1 Day5 Days1 Month6 Months1 Year5 Years
+0.26%-4.14%-0.66%+17.65%-4.23%+107.75%
like16
dislike

Mphasis Achieves Record Q2 Revenue, Launches AI Platform Amid Strong Deal Wins

1 min read     Updated on 05 Nov 2025, 09:09 PM
scanx
Reviewed by
Riya DeyScanX News Team
Overview

Mphasis achieved its highest quarterly revenue of $445 million, up 2% QoQ and 6% YoY in constant currency. The company secured six large deals in Q2, including one over $100 million from a new BFS client. Total Contract Value (TCV) reached $528 million for the second consecutive quarter. Mphasis launched MphasisNeoIP, an AI platform for enterprise transformation, with 69% of its pipeline now AI-led. The company aims for growth exceeding 2x industry growth and targets an EBIT margin of 14.75% to 15.75%.

23902772

*this image is generated using AI for illustrative purposes only.

Mphasis , a leading IT services and solutions provider, has reported its highest quarterly revenue to date, marking significant growth and strategic advancements in the artificial intelligence (AI) domain.

Record-Breaking Financial Performance

Mphasis delivered an impressive financial performance in Q2:

Metric Value Growth
Revenue $445.00 million 2% QoQ, 6% YoY (constant currency)
Total Contract Value (TCV) $528.00 million Second consecutive quarter
EBIT Margin 15.30% Stable
EPS INR 24.70 10.2% YoY

The company's direct business contributed significantly, accounting for 97.5% of overall revenue. Notably, the Banking and Financial Services (BFS) vertical demonstrated robust growth of 13.8% year-over-year, despite the ATM business ramp-down.

Strong Deal Momentum

Mphasis continues to show strong momentum in deal wins:

  • Six large deals secured in Q2, including one exceeding $100.00 million from a new BFS client
  • First half TCV wins of approximately $1.30 billion, surpassing full-year FY25 TCV wins
  • Last 12 months TCV reaching over $2.00 billion

AI-Driven Growth and Innovation

The company is leveraging AI to drive growth and innovation:

  • Launched MphasisNeoIP, an AI platform integrating multiple solutions for enterprise transformation
  • Pipeline reached record levels, growing 97% year-over-year
  • 69% of the pipeline is AI-led, indicating a strong focus on next-generation technologies

Future Outlook

Mphasis has set ambitious targets for the future:

  • Expects growth to be greater than 2x industry growth
  • Targeting EBIT margin in the 14.75% to 15.75% band

The company's strong performance, coupled with its focus on AI-driven solutions and robust deal pipeline, positions it well for continued growth in the competitive IT services landscape.

Historical Stock Returns for Mphasis

1 Day5 Days1 Month6 Months1 Year5 Years
+0.26%-4.14%-0.66%+17.65%-4.23%+107.75%
like20
dislike
More News on Mphasis
Explore Other Articles
2,773.90
+7.30
(+0.26%)